©The Author(s) 2017.
World J Hepatol. Mar 18, 2017; 9(8): 436-442
Published online Mar 18, 2017. doi: 10.4254/wjh.v9.i8.436
Published online Mar 18, 2017. doi: 10.4254/wjh.v9.i8.436
Table 1 Demographic, laboratory and liver fibrosis characteristics
| Characteristics | Patients (n = 81) |
| Gender (male/female) | 40 (49.4%)/41 (50.6%) |
| Age (yr) - median (Q1;Q3) | 51 (30-78) |
| BMI (kg/m2) - median (Q1;Q3) | 26.5 (24.3-29.6) |
| ALT (IU/L) - median (Q1;Q3) | 50 (32.5-85) |
| AST (IU /L) - median (Q1;Q3) | 42 (28.5-61.5) |
| Platelet count (× 103/mm3) - median (Q1; Q3) | 202 (148-247) |
| Histological fibrosis stage, n (%) | |
| F0 | 5 (6.2) |
| F1 | 33 (40.7) |
| F2 | 20 (24.7) |
| F3 | 12 (14.8) |
| F4 | 11 (13.6) |
| TE (kPa) - median (Q1; Q3) | 6.9 (5-12.2) |
| TE success rate (mean ± SD) | 0.92 ± 0.21 |
| CAP (dB/m) - mMedian (Q1; Q3) | 237 (204-263) |
| ARFI (m/s) - median (Q1; Q3) | 1.25 (0.65-2.89) |
| APRI - median (Q1; Q3) | 0.66 (0.41-1.29) |
| FIB-4 - median (Q1; Q3) | 1.41 (0.90-2.45) |
- Citation: Paranaguá-Vezozzo DC, Andrade A, Mazo DFC, Nunes V, Guedes AL, Ragazzo TG, Moutinho R, Nacif LS, Ono SK, Alves VAF, Carrilho FJ. Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C. World J Hepatol 2017; 9(8): 436-442
- URL: https://www.wjgnet.com/1948-5182/full/v9/i8/436.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i8.436